CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Cryoprobe biopsy +1 moredevice
Likely dose
Not stated in record
Key inclusion· 2
  • Patient clinically meets indication for peripheral lung nodule biopsy and has been scheduled for robotic bronchoscopy
  • Pulmonary nodules of 8-50mm in largest dimension
Key exclusion· 6
  • Known bleeding diathesis or platelet count <50,000
  • Current use of systemic anticoagulation or antiplatelet therapy without ability to hold therapy for recommended time prior to procedure (aspirin monotherapy acceptable)
  • Pulmonary hypertension (RVSP >50 mmHg)
  • INR <1.5

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05399082
NCT05399082N/ACompleted

A Study to Evaluate the Feasibility of Robotic Bronchoscopy-guided Miniature Cryoprobe Biopsy of Peripheral Pulmonary Lesions

Mayo Clinic·interventional·Posted Jun 1, 2022·Updated Oct 17, 2024

In Brief

A clinical study evaluating Cryoprobe biopsy and Forceps biopsy for Bronchi--Diseases and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This research is being done to evaluate the feasibility, and biopsy quality, of using a 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 1, 2022
Enrollment StartAug 15, 2022
Primary CompletionJul 11, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.1 years ago

Interventions

Cryoprobe biopsydevice

A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue

Forceps biopsyprocedure

Biopsy forceps used to collect tissue